The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Meisner Lara since 2022.
This trader's CIK number is 1883986.
At the time of last reporting, Meisner Lara was the Chief Legal Officer of Bicara Therapeutics Inc.. (stock ticker symbol BCAX).
Also see all insider trading activities at Bicara Therapeutics Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | BCAX | 0 | $0 | 15,829 | $165,096 | 15,829 | $86,268 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | VRDN | 0 | $0 | 46,610 | $1,365,753 | 16,639 | $309,942 |
2022 | VRDN | 0 | $0 | 25,978 | $681,542 | 25,978 | $524,903 |
1. Bicara Therapeutics Inc. (BCAX)
2. Viridian Therapeutics, Inc.\de (VRDN)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-16 | BCAX | Option Ex | 15,829 | 5.45 | 86,268 |
2025-06-16 | BCAX | Sale | 15,829 | 10.43 | 165,096 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-06-15 | VRDN | Option Ex | 2,269 | 23.03 | 52,255 |
2023-06-16 | VRDN | Option Ex | 27 | 23.03 | 621 |
2023-06-15 | VRDN | Sale | 2,269 | 28.02 | 63,577 |
2023-06-16 | VRDN | Sale | 27 | 28.35 | 765 |
2023-06-06 | VRDN | Option Ex | 5,126 | 18.51 | 94,882 |
2023-06-05 | VRDN | Option Ex | 499 | 18.51 | 9,236 |
2023-06-02 | VRDN | Sale | 1,875 | 24.21 | 45,393 |
2023-06-02 | VRDN | Option Ex | 1,875 | 14.00 | 26,250 |
2023-06-06 | VRDN | Sale | 5,126 | 25.02 | 128,252 |
2023-06-05 | VRDN | Sale | 499 | 25.03 | 12,489 |
2023-03-09 | VRDN | Sale | 29,971 | 29.07 | 871,256 |
2023-01-23 | VRDN | Sale | 6,843 | 35.66 | 244,021 |
2023-01-23 | VRDN | Option Ex | 6,843 | 18.52 | 126,698 |
2022-12-15 | VRDN | Option Ex | 300 | 23.03 | 6,909 |
2022-12-16 | VRDN | Option Ex | 1,297 | 23.03 | 29,869 |
2022-12-15 | VRDN | Sale | 300 | 28.08 | 8,424 |
2022-12-16 | VRDN | Sale | 1,297 | 28.44 | 36,886 |
2022-12-12 | VRDN | Option Ex | 600 | 23.03 | 13,818 |
2022-12-14 | VRDN | Sale | 15,656 | 28.12 | 440,246 |
2022-12-14 | VRDN | Option Ex | 15,656 | 23.03 | 360,557 |
2022-12-12 | VRDN | Sale | 600 | 28.05 | 16,830 |
2022-11-15 | VRDN | Sale | 8,125 | 22.05 | 179,156 |
2022-11-15 | VRDN | Option Ex | 8,125 | 14.00 | 113,750 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meisner Lara (Chief Legal Officer of Bicara Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.